I. T. Gram, T. Norat, S. Rinaldi, L. Dossus, A. Lukanova, B. Tehard, F. Clavel-Chapelon, C. H. Van Gils, P. A. H. Van Noord, P. H. M. Peeters, H. B. Bueno-De-Mesquita, G. Nagel, J. Linseisen, P. H. Lahamann, et al., “Body Mass Index, Waist Circumference and Waist-Hip Ratio and Serum Levels of IGF-I and IGFBP-3 in European Women,” International Journal of Obesity (Lond), Vol. 30, No. 11, 2006, pp. 1623-1631. doi:10.1038/sj.ijo.0803324

has been cited by the following article:

• TITLE: The Effect of Overweight on The Risk of Recurrence in Tunisian Patients with Operable Breast Cancer

  AUTHORS: Inès Ayadi Masmoudi, Amine Masmoudi, Nabil Toumi, Afef Khanfir, Mounir Frikha, Jamel Daoud

  KEYWORDS: Adjuvant Chemotherapy, Early Breast Cancer, Obesity, Recurrence, Tunisia

  JOURNAL NAME: Journal of Cancer Therapy, Vol.2 No.3, August 24, 2011

  ABSTRACT: Obesity is associated with worse breast cancer outcomes in Western and Asian women. The present study was to determine the relation of body mass index (BMI) to disease-free survival (DFS) in Tunisian patients with operable breast cancer. We retrospectively reviewed data from 223 patients with operable breast cancer treated with primary surgery and adjuvant epirubicin-based chemotherapy. Patients were categorized into lower-BMI (2; N=114) v higher-BMI (>27.5 kg/m2; N=113). Patients’and disease characteristics, including tumor size and lymph node status, were similar between the 2 groups. With a median follow-up of 56 months, there were 42 and 30 DFS events in the lower- and higher-BMI group, respectively (adjusted hazard ratio (HR): 0.74; 95% CI, 0.43 to 1.26; p=0.26). A significant interaction (p